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Secreted calmodulin-like skin protein ameliorates 
scopolamine-induced memory impairment
Humanin, a short bioactive peptide, inhibits cell death 
in a variety of cell-based death models via Humanin re-
ceptors in vitro. In vivo, Humanin ameliorates both 
muscarinic receptor antagonist-induced memory impair-
ment in normal mice and memory impairment in Al-
zheimer’s disease AD -relevant mouse models includ-
ing aged transgenic mice expressing a familial AD-
linked gene. Recently, calmodulin-like skin protein 
CLSP  has been shown to be secreted from skin tissues, 
contains a region minimally similar to the core region of 
Humanin, and inhibit AD-related neuronal death via the 
heterotrimeric Humanin receptor htHNR  on the cell 
surface in vitro. Since CLSP is much more potent than 
across the blood-brain barrier to the central nervous sys-
tem CNS , CLSP is regarded as a physiological agonist 
that binds to the htHNR and triggers the Humanin-in-
duced signals in CNS. However, it remains unknown 
whether CLSP ameliorates memory impairment in mouse 
dementia models as Humanin does. In this study, we 
show that recombinant CLSP, administered intracerebro-
ventricularly or intraperitoneally, ameliorates scopol-
amine-induced dementia in mice. This result suggests 
that CLSP has Humanin-like activity in mouse dementia 
models as Humanin does.
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